Anne-Sophie Grandvuinet

Anne-Sophie Grandvuinet has a diverse work experience in the pharmaceutical industry and research field. Anne-Sophie currently works as a Senior Scientist at Symphogen since 2021. Prior to this, they held various roles at Novo Nordisk, starting as a Research Scientist in 2012 and later becoming a Senior Development Professional in 2018. Anne-Sophie also worked as a Formulation Scientist at Novo Nordisk from 2015 to 2018.

Before joining Novo Nordisk, Anne-Sophie was a PhD Candidate at the Faculty of Pharmaceutical Sciences, University of Copenhagen from 2010 to 2013. Additionally, they had a brief role as a Visiting Research Fellow at UCSF in 2012.

Anne-Sophie's early career includes working as a Scientific Officer in the Consumer Safety Division at the Danish Medicines Agency from 2008 to 2009. Anne-Sophie also worked as a Student Assistant in the Licensing Division at the same agency from 2003 to 2007. In 2006, they briefly worked as a Student Assistant at the Pharmacy of Ryparken.

Anne-Sophie Grandvuinet completed their education in a chronological order. Anne-Sophie began their academic journey in 1987 at the Europeen School of Luxembourg, where they received their basic education. From 2001 to 2008, they attended Danmarks Farmaceutiske Universitet, where they obtained a Master of Science degree in Pharmacy with a focus on Pharmaceutical Sciences. Subsequently, they pursued their studies at the University of Melbourne from 2007 to 2008, where they completed a Master's thesis in the field of Pharmacology of Glutamate Transporters. Lastly, from 2010 to 2013, Anne-Sophie Grandvuinet earned a Doctor of Philosophy (PhD) degree in Pharmaceutical Sciences from Københavns Universitet - University of Copenhagen.